PA
VKTX icon

Parallel Advisors’s Viking Therapeutics VKTX Stock Holding History

Parallel Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$540K Sell
13,833
-187
-1% -$6.04K 0.01% 761
2026
Q1 		$456K Buy
14,020
+3,447
+33% +$111K 0.01% 761
2025
Q4 		$372K Buy
10,573
+5,719
+118% +$203K 0.01% 799
2025
Q3 		$128K Buy
4,854
+3,036
+167% +$90.6K ﹤0.01% 1285
2025
Q2 		$48.2K Buy
1,818
+455
+33% +$12K ﹤0.01% 1744
2025
Q1 		$32.9K Buy
1,363
+536
+65% +$16.9K ﹤0.01% 1883
2024
Q4 		$33.3K Sell
827
-216
-21% -$12.3K ﹤0.01% 1888
2024
Q3 		$66K Buy
+1,043
New +$61.2K ﹤0.01% 1462
2024
Q2 		– Sell
-197
Closed -$16.2K – 3432
2024
Q1 		$16.2K Buy
+197
New +$8.77K ﹤0.01% 2095
2022
Q3 		– Sell
-98
Closed – – 3517
2022
Q2 		$0 Sell
98
-1,455
-94% -$3.6K ﹤0.01% 3385
2022
Q1 		$5K Hold
1,553
– – ﹤0.01% 2324
2021
Q4 		$7K Hold
1,553
– – ﹤0.01% 2280
2021
Q3 		$10K Hold
1,553
– – ﹤0.01% 2083
2021
Q2 		$9K Hold
1,553
– – ﹤0.01% 2068
2021
Q1 		$10K Hold
1,553
– – ﹤0.01% 1937
2020
Q4 		$9K Hold
1,553
– – ﹤0.01% 1842
2020
Q3 		$9K Hold
1,553
– – ﹤0.01% 1796
2020
Q2 		$11K Buy
+1,553
New +$10.3K ﹤0.01% 1690
2020
Q1 		– Sell
-1,568
Closed -$13K – 2666
2019
Q4 		$13K Hold
1,568
– – ﹤0.01% 1626
2019
Q3 		$11K Buy
+1,568
New +$11.6K ﹤0.01% 1646

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Parallel Advisors's VKTX Position: Q2 2026 in Review

Parallel Advisors reduced its Viking Therapeutics (VKTX) stake by 1.3% in Q2 2026, selling an estimated $6.04K and leaving 13,833 shares worth $540K. The position accounts for 0.01% of the portfolio, ranked #761.

Parallel Advisors first reported a position in VKTX in Q3 2019 and has held it in 20 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Parallel Advisors held 13,833 shares of Viking Therapeutics worth $540K as of Q2 2026.
  • Parallel Advisors sold 187 Viking Therapeutics shares in Q2 2026, an estimated $6.04K.
  • Viking Therapeutics made up 0.01% of Parallel Advisors's portfolio in Q2 2026, its #761 holding.
  • Parallel Advisors first reported a position in Viking Therapeutics in Q3 2019 and has held it in 20 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.